Iovance Biotherapeutics Inc. buy BiotechBee
Start price
24.06.23
/
50%
€7.14
Target price
30.11.25
€9.00
Performance (%)
7.45%
End price
14.12.24
€7.67
Summary
This prediction ended on 14.12.24 with a price of €7.67. With a performance of 7.45%, the BUY prediction by BiotechBee for Iovance Biotherapeutics Inc. closed with a slight gain. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 35.689% | 35.689% | 254.407% | 37.437% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
According to BiotechBee what are the pros and cons of Iovance Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Lion Biotechnologies Inc diskutieren
Buy mit Kursziel 9,0
In the thread Trading Lion Biotechnologies Inc
Buy beendet

